• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血修饰白蛋白、乳酸及联合检测对急诊科感染性休克患者死亡率的预测价值

Ischemia-Modified Albumin, Lactate, and Combination for Predicting Mortality in Patients with Septic Shock in the Emergency Department.

作者信息

Jin Bo-Yeong, Lee Sukyo, Kim Woosik, Park Jong-Hak, Cho Hanjin, Moon Sungwoo, Ahn Sejoong

机构信息

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Department of Emergency Medicine, Korea University Ansan Hospital, Ansan-si 15355, Republic of Korea.

出版信息

Biomedicines. 2024 Jun 26;12(7):1421. doi: 10.3390/biomedicines12071421.

DOI:10.3390/biomedicines12071421
PMID:39061994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11274077/
Abstract

Ischemia-modified albumin (IMA) is produced during ischemia and reactive oxygen species production. This study aimed to evaluate the association between IMA and mortality in a larger population and the prognostic value of the combination of IMA and lactate for predicting mortality in septic shock patients in the emergency department. This retrospective observational study included adult septic shock patients between October 2019 and December 2021. A multivariable Cox proportional hazards model was performed. IMA was significantly higher in the non-surviving group than in the surviving group (89.1 ± 7.2 vs. 83.8 ± 6.2 U/mL, < 0.001). IMA was independently associated with 28-day mortality after adjustments (adjusted hazard ratio [aHR]: 1.075, 95% confidence interval [CI]: 1.016-1.138, = 0.012). The area under the ROC curve (AUROC) of IMA was 0.712 (95% CI: 0.648-0.775, < 0.001) and was comparable to that of lactate. The AUROC of the combination of IMA and lactate was 0.838 (95% CI: 0.786-0.889, < 0.001). The group with both high lactate and high IMA levels showed an extremely high risk of mortality than other groups (86.1%; aHR 8.956, 95% CI 4.071-19.70, < 0.001). The elevation of IMA was associated with mortality in septic shock patients. The combination of IMA and lactate can be a helpful tool for early risk stratification of septic shock patients.

摘要

缺血修饰白蛋白(IMA)在缺血和活性氧生成过程中产生。本研究旨在评估在更大规模人群中IMA与死亡率之间的关联,以及IMA与乳酸联合用于预测急诊科感染性休克患者死亡率的预后价值。这项回顾性观察性研究纳入了2019年10月至2021年12月期间的成年感染性休克患者。进行了多变量Cox比例风险模型分析。非存活组的IMA显著高于存活组(89.1±7.2 vs. 83.8±6.2 U/mL,P<0.001)。调整后IMA与28天死亡率独立相关(调整后风险比[aHR]:1.075,95%置信区间[CI]:1.016 - 1.138,P = 0.012)。IMA的ROC曲线下面积(AUROC)为0.712(95% CI:0.648 - 0.775,P<0.001),与乳酸的相当。IMA与乳酸联合的AUROC为0.838(95% CI:0.786 - 0.889,P<0.001)。乳酸和IMA水平均高的组比其他组显示出极高的死亡风险(86.1%;aHR 8.956,95% CI 4.071 - 19.70,P<0.001)。IMA升高与感染性休克患者的死亡率相关。IMA与乳酸联合可为感染性休克患者的早期风险分层提供有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/9db10ec3b058/biomedicines-12-01421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/c239cbcb6e92/biomedicines-12-01421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/03eb5ad28212/biomedicines-12-01421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/9db10ec3b058/biomedicines-12-01421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/c239cbcb6e92/biomedicines-12-01421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/03eb5ad28212/biomedicines-12-01421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/11274077/9db10ec3b058/biomedicines-12-01421-g003.jpg

相似文献

1
Ischemia-Modified Albumin, Lactate, and Combination for Predicting Mortality in Patients with Septic Shock in the Emergency Department.缺血修饰白蛋白、乳酸及联合检测对急诊科感染性休克患者死亡率的预测价值
Biomedicines. 2024 Jun 26;12(7):1421. doi: 10.3390/biomedicines12071421.
2
Association of ischemia modified albumin with mortality in qSOFA positive sepsis patients by sepsis-3 in the emergency department.在急诊科,根据 sepsis-3 标准,qSOFA 阳性脓毒症患者中缺血修饰白蛋白与死亡率的关系。
Am J Emerg Med. 2021 Jun;44:72-77. doi: 10.1016/j.ajem.2021.01.059. Epub 2021 Jan 29.
3
Usefulness of ischemia-modified albumin in the diagnosis of sepsis/septic shock in the emergency department.缺血修饰白蛋白在急诊科脓毒症/脓毒性休克诊断中的应用价值
Clin Exp Emerg Med. 2020 Sep;7(3):161-169. doi: 10.15441/ceem.19.075. Epub 2020 Sep 30.
4
The prognostic value of ischemia-modified albumin in patients with sepsis.缺血修饰白蛋白在脓毒症患者中的预后价值。
Niger J Clin Pract. 2021 May;24(5):680-684. doi: 10.4103/njcp.njcp_211_20.
5
The prognostic value of the lactate/albumin ratio for predicting mortality in septic patients presenting to the emergency department: a prospective study.乳酸/白蛋白比值对急诊就诊脓毒症患者死亡率的预测价值:一项前瞻性研究。
Ann Med. 2021 Dec;53(1):2268-2277. doi: 10.1080/07853890.2021.2009125.
6
The prognostic utility of Lactate/Albumin*Age score in septic patient with normal lactate level.乳酸/白蛋白×年龄评分在乳酸水平正常的脓毒症患者中的预后价值。
Heliyon. 2024 Aug 28;10(17):e37056. doi: 10.1016/j.heliyon.2024.e37056. eCollection 2024 Sep 15.
7
[Prognostic value of arterial lactate combined with central venous-to-arterial carbon dioxide difference to arterial-to-central venous oxygen content difference ratio in septic shock patients].动脉血乳酸联合中心静脉与动脉血二氧化碳分压差与动脉血与中心静脉血氧含量差比值对脓毒症休克患者的预后价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):39-43. doi: 10.3760/cma.j.cn121430-20191226-00007.
8
The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy.C反应蛋白/白蛋白比值作为早期目标导向治疗的严重脓毒症或脓毒性休克患者死亡率的独立预测指标
PLoS One. 2015 Jul 9;10(7):e0132109. doi: 10.1371/journal.pone.0132109. eCollection 2015.
9
Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock.脓毒症集束化治疗应用于肝硬化合并感染性休克患者的有效性及预后预测因素
BMC Infect Dis. 2021 May 26;21(1):483. doi: 10.1186/s12879-021-06194-5.
10
[Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].[乳酸、乳酸清除率及降钙素原在评估脓毒症严重程度及预测预后中的作用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):449-453. doi: 10.3760/cma.j.cn121430-20200129-00086.

引用本文的文献

1
Molecular Biomarkers and More Efficient Therapies for Sepsis.脓毒症的分子生物标志物与更有效的治疗方法
Biomedicines. 2025 Feb 14;13(2):468. doi: 10.3390/biomedicines13020468.

本文引用的文献

1
Mortality among adult patients with sepsis and septic shock in Korea: a systematic review and meta-analysis.韩国成年脓毒症和脓毒性休克患者的死亡率:一项系统评价和荟萃分析。
Clin Exp Emerg Med. 2023 Jun;10(2):157-171. doi: 10.15441/ceem.23.005. Epub 2023 Mar 7.
2
Kinetics of d-lactate and ischemia-modified albumin after abdominal aortic surgery and their ability to predict intestinal ischemia.腹主动脉手术后d-乳酸和缺血修饰白蛋白的动力学及其预测肠道缺血的能力。
Clin Biochem. 2023 Feb;112:43-47. doi: 10.1016/j.clinbiochem.2022.12.002. Epub 2022 Dec 8.
3
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021.
执行摘要:拯救脓毒症运动:2021年脓毒症和脓毒性休克管理国际指南。
Crit Care Med. 2021 Nov 1;49(11):1974-1982. doi: 10.1097/CCM.0000000000005357.
4
Ischemia-Modified Albumin: Origins and Clinical Implications.缺血修饰白蛋白:起源与临床意义。
Dis Markers. 2021 Jul 19;2021:9945424. doi: 10.1155/2021/9945424. eCollection 2021.
5
The prognostic value of ischemia-modified albumin in patients with sepsis.缺血修饰白蛋白在脓毒症患者中的预后价值。
Niger J Clin Pract. 2021 May;24(5):680-684. doi: 10.4103/njcp.njcp_211_20.
6
Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation.氧化应激与脓毒症和急性炎症中的内皮功能障碍。
Antioxid Redox Signal. 2021 Nov 20;35(15):1291-1307. doi: 10.1089/ars.2021.0027. Epub 2021 Apr 9.
7
Association of ischemia modified albumin with mortality in qSOFA positive sepsis patients by sepsis-3 in the emergency department.在急诊科,根据 sepsis-3 标准,qSOFA 阳性脓毒症患者中缺血修饰白蛋白与死亡率的关系。
Am J Emerg Med. 2021 Jun;44:72-77. doi: 10.1016/j.ajem.2021.01.059. Epub 2021 Jan 29.
8
Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients.缺血修饰白蛋白,急性主动脉夹层患者院内死亡的一种新型预测标志物。
Front Physiol. 2019 Sep 27;10:1253. doi: 10.3389/fphys.2019.01253. eCollection 2019.
9
Ischemia-modified Albumin as a Biomarker for Prediction of Poor Outcome in Patients With Traumatic Brain Injury: An Observational Cohort Study.缺血修饰白蛋白作为创伤性脑损伤患者预后不良预测的生物标志物:一项观察性队列研究。
J Neurosurg Anesthesiol. 2021 Jul 1;33(3):254-257. doi: 10.1097/ANA.0000000000000647.
10
Mechanisms and treatment of organ failure in sepsis.脓毒症器官衰竭的机制与治疗。
Nat Rev Nephrol. 2018 Jul;14(7):417-427. doi: 10.1038/s41581-018-0005-7.